Nandrolone Phenylpropionate (NPP) 100 mg

Nandrolone Phenylpropionate (NPP) 100 mg is Hilma Biocare's short-ester nandrolone injectable, supplied as a 10 ml vial at 100 mg/ml. The phenylpropionate ester releases and clears far faster than decanoate, giving researchers a responsive nandrolone option with a much shorter window.

What Nandrolone Phenylpropionate Is

Nandrolone phenylpropionate is the same parent hormone as Deca, esterified with phenylpropionic acid instead of decanoic acid. The shorter ester changes everything about the pharmacokinetics: onset is quicker, peak levels arrive sooner and clearance is measured in days rather than weeks. Nandrolone itself remains a low-aromatising, mildly androgenic anabolic, but NPP lets a researcher adjust or stop with far less lag. It is the fast nandrolone in a category dominated by the long decanoate.

The History of NPP

Organon developed nandrolone phenylpropionate in the 1950s and marketed it as Durabolin, the shorter-acting sibling of Deca-Durabolin. Durabolin was used clinically where a faster onset was wanted, including post-operative and wasting contexts. As Deca became the dominant name, NPP persisted in research as the flexible alternative. Its reputation grew in the 1990s and 2000s among researchers who wanted nandrolone's profile without a multi-week tail.

How It Works

Phenylpropionate esters are hydrolysed relatively quickly by tissue esterases, so free nandrolone appears within days and declines over a similar window. The parent hormone binds the androgen receptor, supports protein synthesis and increases bone density, while aromatising at a lower rate than testosterone. Because the ester is short, blood levels can be titrated more precisely than with decanoate, and washout is faster. That is the core pharmacological difference between NPP and Deca. The shorter window also means the compound is cleared from the body more quickly once administration stops, which makes it easier to separate the effects of nandrolone from those of a long-acting depot in a research design.

What the Research Shows

• Nandrolone phenylpropionate was studied clinically as Durabolin in the 1950s and 1960s.
• Comparative work shows phenylpropionate esters release much faster than decanoate.
• Nandrolone's effects on lean mass and bone have been documented in several wasting and osteoporosis trials.
• Short-ester nandrolone is often used in research where rapid clearance is required.

Research Context

Nandrolone phenylpropionate was marketed as Durabolin and studied clinically where a faster onset than decanoate was wanted. Research shows that the phenylpropionate ester is hydrolysed within days, producing a shorter exposure window and faster clearance. That difference is useful in study designs that require rapid washout, but it also means more frequent administration to maintain stable levels. Analytical methods can distinguish NPP from decanoate by their metabolite ratios, which is important in forensic and doping contexts.

Strength, Pack and Authentication

The vial contains 100 mg of nandrolone phenylpropionate per millilitre, or 1000 mg per 10 ml. It is filled under controlled conditions, sealed with a colour-coded flip-off cap and packed in a printed carton stating the compound, strength and volume. A scratch-off security code inside the box links the pack to Hilma Biocare's records.

Buying NPP Online

NPP is one of the most searched short-ester injectables. If you are researching nandrolone phenylpropionate, comparing NPP and Deca or looking to buy NPP online from a trusted Hilma Biocare supplier, this page gives you the complete specification, pack size, price and live stock status. Browse more Hilma Biocare injectables at NotNatty.